A vaccine to prevent HIV could be available in four years and would help the immune system to produce antibodies that fight the virus, said the infectologist and epidemiologist Jorge Sánchez.
In the framework of the 10 World Scientific Conference on HIV (IAS 2019) in Mexico City, the vice president of the Center for Technology, Biomedical and Environmental Research in Lima, Peru, said that these vaccines could be effective for some strains of this Virus.
The idea is that with this new tool the spread of this epidemic can be stopped by at least 65%.
The vaccine has inserts from some parts that resemble parts of the virus, so the ability to be effective for different strains or types of HIV is high, said Sanchez, which is part of the study of the study.
The development of the vaccine has been 12 years and was tested on apes, so there have been studies in phase 1, 1b and 2a, which are prior phases to evaluate efficacy in humans.
The study is called mosaic and will be conducted by researchers from the National Institute of Allergic and Infectious Diseases, the National Institutions of Health, the HIV Vaccine Test Network and the United States. There. Army Medical Research and Development Command.
The research to begin in September will be done in 3,800 people from Argentina, Brazil, Italy, Mexico, Peru, Poland, Spain and the United States, from 55 clinical sites around the world, and will be participating in 125 Mexicans from different cities. .